Ready 8-Ks
7
Latest filing
January 26, 2026, 6:59 PM ET
Top materiality
0.75
Event mix
other ×3 · regulatory ×2 · other_material ×1
Sentiment
2 pos · 0 neg · 5 neu
Recent 8-K filings for DXR
Highest-materiality recent filing
Daxor acquires worldwide rights to Volumex, Megatope, and Glofil from Iso-Tex Diagnostics
- No upfront payment; seller-financed with monthly installments starting after manufacturing transition in 6–9 months.
- Deal expected to be immediately accretive and cash flow positive due to higher margins from in-house production.
-
Daxor raises ~$8.1M in registered direct offering of 765,958 shares at $11.75/share
Sold 765,958 shares at $11.75 per share for net proceeds of approx. $8,142,006 after fees.
-
Daxor receives FDA 510(k) clearance for next-gen blood volume analyzer
FDA 510(k) clearance (K251087) for patent-pending rapid, hand-held BVA device.
-
Daxor acquires worldwide rights to Volumex, Megatope, and Glofil from Iso-Tex Diagnostics
No upfront payment; seller-financed with monthly installments starting after manufacturing transition in 6–9 months.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.25 · Most common event other